Prime Medicine Inc (PRME)

SG&A Expense Growth

-36.56%

Quarterly · Period ending:

PRME logo

PRME SG&A Expense Growth

Latest reported-36.56%
PRME Quarterly SG&A Growth (QoQ) (0.00% → -36.56%)
High-resolution chart · PNG

PRME sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Prime Medicine Inc SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
-36.5585%
18.1041%
31.4864%
-14.5536%
-1.2572%
7.9912%
-12.7651%
11.9038%
12.9324%
-14.7203%
24.6927%
-1.5481%
16.4427%
-4.9039%
45.6568%
-10.2783%
18.3893%
-13.4409%
137.4298%
161.1734%
-16.5587%
3.8117%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.